secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0000009326-25-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem Q3 2025: record sales $267.6M, adj. EPS $1.35, all segments grow
------------------------------------------------------------------------

- Record net sales $267.6M (+11.5% YoY); GAAP EPS $1.24 vs $1.03; adjusted EPS $1.35 vs $1.13.
- Record adjusted EBITDA $71.4M (+11.0% YoY); free cash flow $50.7M.
- All three segments achieved sales and earnings growth; new NY microencapsulation plant to double capacity.
- Net debt reduced to $88.9M, leverage 0.3x; repaid $36M on revolver during Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/0000009326-25-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/bcpc-20251021.htm
  HTML page:      https://secwatch.observer/filing/0000009326-25-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer